SCF ENCYCLOPEDIA ENTRY

PELVIC FLOOR MYALGIA (POSTPARTUM)

SCF-RDOS Registry Code: SCF-RDOS-PPD-PFD-012

Disease Type Classification: Postpartum Pelvic Floor Disorder → Pelvic Neuromuscular Pain Syndrome → Pelvic Floor Myalgia (PFM)

SCF Classification Status: Postpartum Pelvic Myofascial Pain Disorder

SCF Severity Classification: Hypertonic Neuromuscular Pelvic Dysfunction Syndrome

ADAPTIVE MODULE ACTIVATION

• Universal Core Module
• Pelvic Floor Biology Expansion
• Myofascial Biology Expansion
• Neuromuscular Biology Expansion
• Pain Biology Expansion
• Neuroinflammation Expansion
• Connectomics Expansion
• Biomechanicalomics Expansion
• Psychoneuroimmunology Expansion
• Maternal Recovery Biology Expansion
• Rehabilitation Biology Expansion
• SCF Pathophysiology Protocol — Extended Version
• SCF Universal Cross-System Analysis Module

1. ETIOPATHOGENIC CORE

Definition

Pelvic Floor Myalgia (PFM) is a chronic or recurrent pain disorder characterized by excessive tension, spasm, trigger point formation, neuromuscular dysfunction, and myofascial hypersensitivity within the pelvic floor musculature.

In postpartum patients, the disorder commonly develops following:

• Pregnancy-associated biomechanical stress
• Childbirth-related muscular injury
• Levator ani trauma
• Connective tissue strain
• Persistent guarding responses
• Neurological sensitization
• Maladaptive recovery patterns

SCF Definition

Pelvic Floor Myalgia is a postpartum neuromuscular pain syndrome characterized by persistent hyperactivity, myofascial dysfunction, trigger point formation, and neuroinflammatory sensitization of the pelvic floor musculature resulting in pain, dysfunction, and impaired pelvic system integration.

2. SCF FAULT ARCHITECTURE

Primary SCF Fault Domain

Hypertonic Pelvic Floor Syndrome

Affected Structures

• Levator ani complex
• Pubococcygeus
• Iliococcygeus
• Puborectalis
• Coccygeus
• Obturator internus
• Deep pelvic stabilizers

Primary Failure

Loss of physiologic muscle relaxation

Myofascial Dysfunction

Affected Structures

• Intramuscular fascial planes
• Myotendinous junctions
• Pelvic connective tissue matrix

Primary Failure

Persistent trigger point generation

Neurogenic Pain Amplification

Affected Systems

• Pudendal nerve
• Pelvic autonomic pathways
• Sacral sensory circuits

Primary Failure

Pain signal amplification

Connectomic Dysregulation

Affected Systems

• Brain–pelvic floor networks
• Motor coordination pathways
• Pain modulation circuits

Primary Failure

Persistent maladaptive activation loops

3. MOLECULAR MULTI-OMICS PATHOGENESIS MAP

Genomics

Affected Pathways

• Pain susceptibility genes
• Connective tissue regulation pathways
• Muscle recovery pathways

Epigenomics

Features

• Chronic pain-associated remodeling
• Stress-related neuromuscular programming
• Neuroinflammatory adaptation

Transcriptomics

Activated Pathways

• Myofibroblast signaling
• Neuroplastic pain pathways
• Inflammatory response pathways

Examples

• TGF-β
• NF-κB
• COX-2
• Substance P signaling

Proteomics

Elevated Biomarkers

• IL-6
• TNF-α
• NGF
• BDNF
• Substance P
• CGRP

Metabolomics

Features

• Local tissue hypoxia
• Lactate accumulation
• Altered muscular energetics

Neuroimmunomics

Features

• Neurogenic inflammation
• Glial activation
• Central sensitization

Connectomics

Features

• Altered pain-processing networks
• Pelvic motor network dysregulation
• Reduced inhibitory control

Biomechanicalomics

Features

• Chronic pelvic loading abnormalities
• Muscular shortening patterns
• Asymmetric force transmission

4. SCF PATHOGENESIS FLOW

Pregnancy

↓

Pelvic Loading

↓

Labor and Delivery

↓

Muscle Overstretch Injury

↓

Protective Muscle Guarding

↓

Persistent Hypertonicity

↓

Trigger Point Formation

↓

Neuroinflammatory Sensitization

↓

Chronic Pelvic Pain

↓

Pelvic Floor Myalgia

↓

Recovery

or

↓

Persistent Pelvic Dysfunction

5. PATHOGENS → SYMPTOMATOLOGY → SCF FAULT TIER MAPPING

6. ANATOMICAL SCF MAP

Levator Ani Complex

Functions

• Pelvic organ support
• Continence control
• Pelvic stabilization

Primary Dysfunction

Muscle spasm and shortening

Puborectalis

Functions

• Anorectal support
• Continence regulation

Primary Dysfunction

Painful hypercontraction

Obturator Internus

Functions

• Pelvic stabilization
• Hip-pelvic coordination

Primary Dysfunction

Myofascial trigger points

Pudendal Nerve

Functions

• Sensory and motor pelvic regulation

Primary Dysfunction

Mechanical irritation and sensitization

Sacral Neural Networks

Functions

• Motor control
• Pain modulation

Primary Dysfunction

Sensitization and dysregulation

7. CLINICAL PRESENTATION

Pain Symptoms

Pelvic Pain

• Deep pelvic aching
• Pressure sensation
• Burning discomfort

Perineal Pain

• Vaginal pain
• Rectal pain
• Perineal tenderness

Sexual Pain

• Dyspareunia
• Pain with penetration
• Post-coital pain

Functional Pain

• Sitting intolerance
• Exercise-induced pain
• Defecation-associated pain

Associated Dysfunction

• Urinary urgency
• Urinary frequency
• Incomplete bladder emptying sensation
• Constipation
• Defecatory dysfunction
• Pelvic pressure
• Sexual dysfunction

8. SCF FUNCTIONAL MATRIX

9. CLINICAL PHENOTYPES

Phenotype A — Hypertonic Myalgia

Characteristics

• Predominant muscle spasm
• Minimal central sensitization

Phenotype B — Trigger Point Myalgia

Characteristics

• Localized trigger points
• Referred pain patterns

Phenotype C — Neurogenic Myalgia

Characteristics

• Pudendal irritation
• Neuropathic pain features

Phenotype D — Dyspareunia-Dominant Myalgia

Characteristics

• Sexual pain predominates

Phenotype E — Central Sensitization Myalgia

Characteristics

• Widespread pain amplification
• Persistent symptoms

10. DIAGNOSTIC FRAMEWORK

Clinical Assessment

Core Symptoms

• Chronic pelvic pain
• Pain with intercourse
• Pelvic pressure
• Defecatory pain
• Urinary dysfunction

Physical Examination

Findings

• Pelvic floor tenderness
• Trigger points
• Hypertonicity
• Reduced relaxation capacity
• Reproduction of symptoms during palpation

Diagnostic Studies

Pelvic Floor Assessment

Purpose

• Evaluate muscle tone and coordination

Pelvic MRI

Purpose

• Exclude structural pathology

Pelvic Ultrasound

Purpose

• Assess associated pelvic disorders

Neurophysiologic Testing

Purpose

• Evaluate pudendal and sacral pathways when indicated

11. SCF TRINITY FRAMEWORK

Structural Integrity Failure

Affected Structures

• Pelvic floor muscles
• Fascial planes
• Neuromuscular junctions

Primary Failure

Myofascial dysfunction

Energetic Integrity Failure

Affected Systems

• Muscular metabolism
• Tissue oxygenation
• Recovery pathways

Primary Failure

Energetic inefficiency and fatigue

Informational Integrity Failure

Affected Systems

• Pain modulation pathways
• Motor coordination systems
• Pelvic control networks

Primary Failure

Persistent maladaptive activation

12. SCF THERAPEUTIC MECHANISMS (SCF-PCR)

PREVENTATIVE

Objectives

Prevent chronic pelvic hypertonicity.

Targets

• Early postpartum rehabilitation
• Biomechanical optimization
• Stress reduction
• Pelvic mobility preservation

CURATIVE

Objectives

Reduce pain and restore muscle function.

Targets

• Trigger points
• Hypertonicity
• Neuromuscular dysfunction
• Pain amplification

Clinical Interventions

• Pelvic floor physical therapy
• Myofascial release
• Trigger point therapy
• Relaxation training
• Biofeedback

RESTORATIVE

Objectives

Reconstruct integrated pelvic neuromuscular regulation.

Targets

• Motor control restoration
• Pain normalization
• Connectomic reintegration
• Functional recovery

Potential SCF Strategies

• Precision neuromodulation
• Neurorestorative rehabilitation platforms
• Connectomic motor retraining systems
• Regenerative myofascial therapies

13. CURRENT STANDARD OF CARE

First-Line Management

• Pelvic floor physical therapy
• Myofascial release techniques
• Trigger point treatment
• Biofeedback therapy
• Relaxation and breathing retraining

Adjunctive Therapies

• Neuropathic pain medications when indicated
• Vaginal muscle relaxation strategies
• Behavioral pain management

Advanced Interventions

• Trigger point injections
• Botulinum toxin injections in selected refractory cases
• Multidisciplinary pelvic pain programs

14. TRANSLATIONAL BLUEPRINT

Biomarker Targets

Neuroinflammation

• IL-6
• TNF-α
• Substance P

Neural Plasticity

• NGF
• BDNF

Muscle Injury

• CK
• Myokine signatures

Clinical Endpoints

Primary

• Pelvic pain reduction

Secondary

• Improved sexual function
• Reduced urinary symptoms
• Improved bowel function
• Improved quality of life

15. PROJECT RHENOVA — INTEGRATION PATHWAYS

RHENOVA-A

Myofascial Restoration

RHENOVA-B

Pelvic Neuromuscular Recovery

RHENOVA-C

Pain Circuit Recalibration

RHENOVA-D

Neural Regeneration Optimization

RHENOVA-E

Continence Function Reintegration

RHENOVA-F

Maternal Functional Recovery

16. NEXT STRATEGIC RESEARCH PATHWAYS

Priority 1

Pelvic myalgia biomarker panels

Priority 2

Pelvic pain connectome mapping

Priority 3

Precision pelvic neuromodulation

Priority 4

Neuroimmune-pelvic interaction models

Priority 5

AI-assisted pain phenotype prediction

Priority 6

Integrated postpartum pelvic recovery platforms

17. SCF DBI INTERPRETATION

Decentralized Biological Intelligence Failure

Cellular Layer

Muscle and neural cells adopt persistent protective activation states.

Tissue Layer

Pelvic floor tissues lose coordinated relaxation–contraction cycling.

Organ Layer

Pelvic support systems become locked into maladaptive defensive patterns.

System Layer

Neuromuscular, autonomic, pain-processing, and biomechanical networks become chronically dysregulated.

Whole-Organism Layer

The maternal organism develops a persistent pelvic defense state characterized by pain amplification, impaired relaxation, and functional pelvic floor dysfunction.

18. SCF LAYMAN’S SUMMARY

Pelvic Floor Myalgia is a condition in which the pelvic floor muscles become overly tight, painful, and unable to relax normally after childbirth.

Instead of remaining flexible and responsive, the muscles stay contracted and may develop painful trigger points. This can cause:

• Pelvic pain
• Pain during intercourse
• Urinary symptoms
• Bowel difficulties
• Pelvic pressure
• Sitting discomfort

The condition is often treatable with specialized pelvic floor physical therapy, myofascial treatment, relaxation training, and targeted rehabilitation aimed at restoring normal muscle function.

SCF-RDOS INDICATION SUMMARY

INDEX

SCF Master Registry Classification

• SCF-RDOS-PPD-PFD-001 — Pelvic Floor Dysfunction
• SCF-RDOS-PPD-PFD-005 — Chronic Postpartum Pain Syndrome
• SCF-RDOS-PPD-PFD-010 — Anal Incontinence
• SCF-RDOS-PPD-PFD-011 — Fecal Incontinence
• SCF-RDOS-PPD-PFD-012 — Pelvic Floor Myalgia
• SCF-RDOS-PPD-PFD-013 — Pelvic Floor Hypertonicity Syndrome (Reserved)
• SCF-RDOS-PPD-PFD-014 — Pudendal Neuralgia (Reserved)

Domain Pathway

Postpartum Disorders → Pelvic Floor Disorders → Pelvic Pain Syndromes → Pelvic Floor Myalgia

Adaptive Modules Applied

Universal Core Module + Pelvic Floor Biology Expansion + Myofascial Biology Expansion + Neuromuscular Biology Expansion + Pain Biology Expansion + Neuroimmunology Expansion + Connectomics Expansion + Rehabilitation Biology Expansion + Maternal Recovery Biology Expansion

SCF Encyclopedia Series

Maternal Postpartum Disorders Encyclopedia (Pelvic Pain Medicine, Myofascial Disorders, Neuromuscular Rehabilitation & Maternal Recovery Volume) — Version 1.0.0